BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19007977)

  • 21. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
    Cole LA; Khanlian SA; Muller CY
    J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical use of HCG and hCG beta determinations.
    Mann K; Saller B; Hoermann R
    Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE; Cracchiolo BM; Cole LA
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial adenocarcinoma with trophoblastic differentiation.
    Bradley CS; Benjamin I; Wheeler JE; Rubin SC
    Gynecol Oncol; 1998 Apr; 69(1):74-7. PubMed ID: 9571002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological functions of hCG and hCG-related molecules.
    Cole LA
    Reprod Biol Endocrinol; 2010 Aug; 8():102. PubMed ID: 20735820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumor markers in gynecologic malignancies].
    Tojo S; Suzuki A; Fujii S; Ashitaka Y; Maruo T; Matsuura S
    Gan No Rinsho; 1983 May; 29(6):678-83. PubMed ID: 6192268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects.
    Sisinni L; Landriscina M
    Adv Exp Med Biol; 2015; 867():159-76. PubMed ID: 26530366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tumor markers in gynecological and breast cancer].
    Jobo T; Sato R; Kuramoto H
    Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.
    Cole LA; Muller CY
    Gynecol Oncol; 2010 Jan; 116(1):3-9. PubMed ID: 19822356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular heterogeneity of hCGbeta--related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
    Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-32. PubMed ID: 9833612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease.
    Cole LA
    J Reprod Med; 1998 Jan; 43(1):3-10. PubMed ID: 9475142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
    Faranesh R; Ben-David Y
    Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human chorionic gonadotropin: properties and assay methods.
    Tyrey L
    Semin Oncol; 1995 Apr; 22(2):121-9. PubMed ID: 7740312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review: hCGs: different sources of production, different glycoforms and functions.
    Fournier T; Guibourdenche J; Evain-Brion D
    Placenta; 2015 Apr; 36 Suppl 1():S60-5. PubMed ID: 25707740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New endocrine tumor markers of gynecologic malignancies. A review.
    Kauppila A; Santala M
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):833-7. PubMed ID: 10577610
    [No Abstract]   [Full Text] [Related]  

  • 38. Endometrial adenocarcinoma associated with elevated serum concentrations of the free beta subunit of human chorionic gonadotropin.
    Grenache DG; Moller KA; Groben PM
    Am J Clin Pathol; 2004 May; 121(5):748-53. PubMed ID: 15151215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hCG, five independent molecules.
    Cole LA
    Clin Chim Acta; 2012 Jan; 413(1-2):48-65. PubMed ID: 22027338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The classification, functions and clinical use of different isoforms of HCG.
    Stenman UH; Tiitinen A; Alfthan H; Valmu L
    Hum Reprod Update; 2006; 12(6):769-84. PubMed ID: 16877746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.